BBB Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Leiden Netherlands (2003)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2011
NCT01386580
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

BBB-Therapeutics B.V.